Walleye Capital LLC Alpine Immune Sciences, Inc. Transaction History

Walleye Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.75 - $41.6 $2.84 Million - $6.65 Million	-159,836 Reduced 43.68%	206,104 $8.17 Million
Q4 2023 Feb 14, 2024	BUY	$8.54 - $20.22 $1.53 Million - $3.63 Million	179,667 Added 96.45%	365,940 $6.97 Million
Q3 2023 Nov 14, 2023	BUY	$10.13 - $13.98 $218,808 - $301,968	21,600 Added 13.12%	186,273 $2.13 Million
Q2 2023 Aug 14, 2023	BUY	$6.84 - $11.91 $893,003 - $1.55 Million	130,556 Added 382.67%	164,673 $1.69 Million
Q1 2023 May 15, 2023	BUY	$7.0 - $8.75 $238,819 - $298,523	34,117 New	34,117 $263,000
Q3 2022 Nov 14, 2022	BUY	$6.89 - $9.39 $491,635 - $670,023	71,355 New	71,355 $514,000
Q2 2022 Aug 08, 2022	SELL	$6.71 - $9.52 $280,115 - $397,421	-41,746 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$6.41 - $13.89 $438,142 - $949,423	-68,353 Reduced 62.08%	41,746 $374,000
Q4 2021 Mar 03, 2022	BUY	$10.41 - $13.95 $1.15 Million - $1.54 Million	110,099 New	110,099 $1.52 Million

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.